BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,236,151 | +27.7% | 18,160 | +53.1% | 0.18% | +34.8% |
| Q2 2023 | $968,132 | +7.7% | 11,860 | -2.2% | 0.14% | 0.0% |
| Q1 2023 | $899,331 | +9.0% | 12,122 | +21.8% | 0.14% | +5.5% |
| Q4 2022 | $824,822 | +13.0% | 9,952 | +287.2% | 0.13% | +15.3% |
| Q3 2022 | $730,000 | -43.4% | 2,570 | -30.9% | 0.11% | -39.3% |
| Q2 2022 | $1,289,000 | -20.0% | 3,718 | -0.1% | 0.18% | +5.2% |
| Q1 2022 | $1,611,000 | -10.4% | 3,721 | +7.1% | 0.17% | -2.8% |
| Q4 2021 | $1,797,000 | +37.0% | 3,474 | +28.3% | 0.18% | +50.4% |
| Q3 2021 | $1,312,000 | +28.9% | 2,708 | +19.8% | 0.12% | +29.3% |
| Q2 2021 | $1,018,000 | +60.6% | 2,261 | +36.1% | 0.09% | +55.9% |
| Q1 2021 | $634,000 | -8.9% | 1,661 | -24.2% | 0.06% | -11.9% |
| Q4 2020 | $696,000 | +31.8% | 2,191 | +2.8% | 0.07% | +6.3% |
| Q3 2020 | $528,000 | +142.2% | 2,131 | +158.3% | 0.06% | +125.0% |
| Q2 2020 | $218,000 | -68.8% | 825 | -89.4% | 0.03% | -82.9% |
| Q4 2015 | $699,000 | -13.7% | 7,763 | -11.4% | 0.16% | -13.7% |
| Q3 2015 | $810,000 | -52.7% | 8,763 | -49.6% | 0.19% | +1.6% |
| Q2 2015 | $1,714,000 | +96.3% | 17,400 | +100.0% | 0.19% | +5.1% |
| Q1 2015 | $873,000 | +8.6% | 8,700 | 0.0% | 0.18% | +11.2% |
| Q4 2014 | $804,000 | – | 8,700 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |